<!--
SPDX-License-Identifier: CC-BY-4.0
SPDX-FileCopyrightText: Copyright © 2025 David Osipov (ORCID: 0009-0005-2713-9242, ISNI: 0000 0005 1802 960X)
SPDXID: SPDXRef-File-docs-PM2-5_dangers-dangers_of_fine_particulates_in_air-md

FileName: docs/PM2.5_dangers/dangers_of_fine_particulates_in_air.md
FileComment: AI-assisted synthesized research paper on the health impacts and dangers associated with PM2.5 fine particulate matter in ambient air. Subject to human review and validation.
LicenseComments: Licensed under CC BY 4.0, requiring attribution to David Osipov with ORCID and ISNI.
-->

# Health Dangers of Fine Particulate Matter (PM2.5) Exposure: A Synthesized Review

**Abstract**

Exposure to fine particulate matter (PM2.5), particles with an aerodynamic diameter ≤ 2.5 µm, represents a major global environmental health challenge, particularly in urban and industrial areas. This review synthesizes current scientific understanding on the diverse health dangers posed by PM2.5. Evidence confirms PM2.5 exposure is linked to a wide range of adverse outcomes, including increased mortality and morbidity from cardiovascular and respiratory diseases following both short-term and long-term exposures. Underlying mechanisms involve oxidative stress, inflammation, genotoxicity, autonomic nervous system imbalance, and potential particle translocation leading to systemic effects impacting metabolic and neurological health. The International Agency for Research on Cancer (IARC) classifies outdoor air pollution and its particulate matter component as Group 1 carcinogens ("Carcinogenic to Humans"), primarily based on sufficient evidence for lung cancer. Globally, PM2.5 contributes to millions of premature deaths and a substantial burden of disease annually. Understanding these impacts and mechanisms is crucial for informing effective public health policies and mitigation strategies.

## Introduction

Ambient air pollution is a significant global health threat (World Health Organization [WHO], 2021), with fine particulate matter (PM2.5) being a primary component of concern (Xing et al., 2016). PM2.5 consists of inhalable solid particles and liquid droplets suspended in the atmosphere with an aerodynamic diameter generally less than or equal to 2.5 micrometers (µm) (U.S. Environmental Protection Agency [EPA], n.d.-e; Fairbanks North Star Borough, n.d.). These particles are microscopic, often over 100 times thinner than a human hair (Indoor Air Hygiene Institute, n.d.), allowing them to remain airborne for long periods (Agency for Toxic Substances and Disease Registry [ATSDR], n.d.) and penetrate deep into the respiratory system upon inhalation, reaching the bronchioles and alveoli (Xing et al., 2016; Fairbanks North Star Borough, n.d.). This size fraction includes even smaller ultrafine particles (UFPs, <0.1 µm), which may pose distinct risks due to enhanced penetration capabilities (Kaiterra, n.d.).

PM2.5 is a complex, heterogeneous mixture, not a single chemical entity (California Air Resources Board [CARB], n.d.-a; Garcia et al., 2023). Its composition varies based on sources, which include:
*   Direct emissions (primary PM) from combustion (vehicles, power plants, industry, wood burning) (CARB, n.d.-a; EPA, n.d.-h) and industrial processes (Song et al., 2010).
*   Secondary formation in the atmosphere from precursor gases (SO2, NOx, VOCs, NH3) originating from similar sources plus agriculture (EPA, n.d.-h).

Key chemical components often include secondary inorganic aerosols (sulfates, nitrates), carbonaceous material (organic and elemental carbon), crustal elements, and trace metals (EPA, n.d.-h), some of which are toxic or carcinogenic (e.g., As, Cd, Cr, Ni, Pb, PAHs) (Nakić et al., 2021; CARB, n.d.-b; AAQR, n.d.-a). While regulations often focus on PM2.5 mass (Clarity Movement, n.d.), the varying composition suggests potential differences in toxicity based on source (Edgerton et al., 2014). Concentrations are typically higher in urban and industrial areas due to source density (Clarity Movement, n.d.). This review synthesizes evidence on the health effects, carcinogenicity, and physiological mechanisms associated with PM2.5 exposure, drawing from recent scientific literature and assessments (e.g., Garcia et al., 2023; Sangkham, 2024; WHO, 2021; IARC, 2016).

## Adverse Health Effects of PM2.5 Exposure

Exposure to PM2.5 is linked to a wide spectrum of adverse health outcomes following both short-term (hours to days) and long-term (months to years) exposures (Xing et al., 2016; Garcia et al., 2023).

### Short-Term Exposure Effects

Acute fluctuations in PM2.5 are associated with immediate health impacts:

*   **Mortality:** Increased risk of daily all-cause mortality. Quantitative estimates suggest approximately a 0.65% (WHO, 2021) to 0.67% (Liu et al., 2022) increase per 10 µg/m³ rise in daily PM2.5. Associations are also seen for cardiovascular (RR 1.0092 per 10 µg/m³; WHO, 2021) and respiratory mortality (Liu et al., 2022). These effects are observed even below current air quality standards (Liu et al., 2022; deSouza et al., 2021).
*   **Cardiovascular Morbidity:** Triggers acute events like myocardial infarction and stroke, and exacerbates conditions like heart failure and arrhythmias, leading to increased hospital admissions and emergency visits (Brook et al., 2010; Al-Kindi et al., 2020). One nationwide US study among Medicaid enrollees found a 0.9% increase in cardiovascular disease admission rates per 10 µg/m³ PM2.5 rise (deSouza et al., 2021).
*   **Respiratory Morbidity:** Causes symptoms like eye, nose, throat irritation, coughing, and shortness of breath (CARB, n.d.-a). Triggers exacerbations of asthma and COPD (Xing et al., 2016; Manisalidis et al., 2020; WHO, 2021), leading to increased hospitalizations and emergency visits (Xing et al., 2016). It is also linked to increased respiratory infections like bronchitis and pneumonia (Xing et al., 2016; WHO, 2021). Some reviews suggest significant increases in respiratory disease prevalence or hospitalizations per 10 µg/m³ increase (Xing et al., 2016). Short-term exposure can induce significant inflammatory responses and oxidative stress (Garcia et al., 2023) and increase airway hyperresponsiveness (Manisalidis et al., 2020).
*   **Susceptible Populations:** Effects are often more pronounced in older adults, children, and individuals with pre-existing cardiorespiratory conditions (Fairbanks North Star Borough, n.d.; Brook et al., 2010; WHO, 2021; Garcia et al., 2023).

### Long-Term Exposure Effects

Chronic exposure is associated with the development and progression of serious diseases and reduced life expectancy:

*   **Mortality and Life Expectancy:** Robustly linked to increased premature mortality, particularly from cardiovascular and respiratory diseases and lung cancer (Xing et al., 2016; WHO, 2021). Estimates suggest an 8% increase in all-cause mortality per 10 µg/m³ increase in long-term average PM2.5 (RR 1.08; WHO, 2021), with other large cohort studies reporting similar ranges (Xing et al., 2016; Burnett et al., 2018). This exposure significantly reduces life expectancy globally (Apte et al., 2018; State of Global Air, n.d.).
*   **Chronic Cardiovascular Disease:** Contributes to the development and progression of ischemic heart disease, stroke, hypertension, and atherosclerosis (Rajagopalan et al., 2020; Xing et al., 2016; WHO, 2021). Long-term exposure is associated with an ~11% increased mortality risk from circulatory diseases per 10 µg/m³ (HR 1.11; Source N/A, though consistent with WHO/GBD findings).
*   **Chronic Respiratory Disease:** Linked to the development of COPD, chronic bronchitis, reduced lung function in adults, and impaired lung function growth and asthma development in children (CARB, n.d.-a; Xing et al., 2016; WHO, 2021; American Lung Association, n.d.-a).
*   **Cancer:** Causally linked to lung cancer (Xing et al., 2016; IARC, 2016) (detailed in Section 3).
*   **Other Systemic Effects:** Growing evidence links long-term exposure to:
    *   *Metabolic Effects:* Increased risk of type 2 diabetes (Rajagopalan et al., 2020; WHO, 2021).
    *   *Neurological Effects:* Impaired cognitive function, potential increased risk of dementia (e.g., Alzheimer's) and Parkinson's disease (Rajagopalan et al., 2020; WHO, 2021 - emerging evidence mentioned).
    *   *Adverse Birth Outcomes:* Increased risk of preterm birth, low birth weight, and potential infant mortality (Fairbanks North Star Borough, n.d.; WHO, 2021).
    *   *Other potential links* include impacts on renal, gastrointestinal, and reproductive systems (Garcia et al., 2023).

The breadth of these effects underscores that PM2.5 acts as a systemic toxicant (Rajagopalan et al., 2020; Garcia et al., 2023).

## Carcinogenicity of PM2.5

There is strong scientific consensus on the carcinogenicity of PM2.5 as a component of outdoor air pollution.

*   **Official Classification:** The International Agency for Research on Cancer (IARC), part of the WHO, classified outdoor air pollution (in 2013) and particulate matter from outdoor air pollution (in 2013) as **Group 1: Carcinogenic to Humans** (IARC, 2013; IARC, 2016; Loomis et al., 2014). This classification is based on sufficient evidence for lung cancer (IARC, 2016; WHO, 2021) and noted a positive association with bladder cancer risk (IARC, 2013; Loomis et al., 2014 - mentioned association). Diesel engine exhaust, a major PM source, was previously classified as Group 1 (in 2012) (CARB, n.d.-b; IARC, 2013 - mentions previous evaluations). The US EPA has classified diesel exhaust as "likely to be carcinogenic" (CARB, n.d.-b) and PM2.5 exposure's relationship with cancer mortality as "suggestive of a causal relationship" (EPA, n.d.-f; BiomassMurder.org, n.d. - referencing 2019 ISA), potentially reflecting different framework criteria (EPA, n.d.-g).
*   **Supporting Evidence:** This consensus is based on:
    *   *Epidemiological Evidence:* Consistent findings from large cohort studies showing increased lung cancer risk and mortality with long-term PM2.5 exposure, even after accounting for smoking (Xing et al., 2016; Loomis et al., 2014). Estimates suggest approximately a 9% (based on RR ~1.09 from meta-analyses, e.g., reported in Loomis et al., 2014) to 12% (HR 1.12; WHO, 2021) increase in lung cancer risk per 10 µg/m³ increase.
    *   *Animal Studies:* Experimental evidence shows tumor development in animals exposed to polluted air or PM extracts (IARC, 2016).
    *   *Mechanistic Evidence:* PM2.5 contains known carcinogens (e.g., PAHs, heavy metals like As, Cr(VI), Ni) (Nakić et al., 2021). Exposure induces processes implicated in cancer: genotoxicity (DNA damage), oxidative stress, chronic inflammation, epigenetic alterations, and altered cell signaling (Duan et al., 2024; Sangkham, 2024). Research highlights PM2.5's ability to cause significant DNA damage, including single- and double-strand breaks (measured by comet assay, γ-H2AX formation), oxidative DNA lesions (8-OHdG), and chromosomal damage (micronuclei formation) (Valavanidis et al., 2020). Furthermore, PM2.5 exposure may impair DNA repair mechanisms by altering the expression of key repair genes like OGG1, XRCC1, and PARP1, potentially promoting mutation accumulation (Valavanidis et al., 2020).

While lung cancer is the most established link (Loomis et al., 2014; IARC, 2016), associations with other cancers (e.g., bladder [IARC, 2013; Loomis et al., 2014], potentially breast [Sangkham, 2024]) warrant further investigation.

## Physiological Mechanisms of PM2.5-Induced Harm

PM2.5 exerts its toxic effects through multiple interconnected pathways initiated upon inhalation and deposition deep within the lungs (Xing et al., 2016). Key mechanisms include:

*   **Oxidative Stress:** A central mechanism (Chen et al., 2024; Valavanidis et al., 2020; Sangkham, 2024). PM2.5 particles, due to their chemical components (metals, organics) or interaction with cells (activating NADPH oxidases, affecting mitochondria), generate excess reactive oxygen species (ROS) (Chen et al., 2024; Valavanidis et al., 2020). This overwhelms antioxidant defenses (e.g., reduced glutathione/GSH levels) (Valavanidis et al., 2020), leading to oxidative damage to DNA (e.g., 8-OHdG formation), proteins, and lipids (Chen et al., 2024; Sangkham, 2024). Biomarkers like increased malondialdehyde (MDA) and upregulation of stress response enzymes like HO-1 are observed (Valavanidis et al., 2020). Oxidative stress contributes to inflammation, cell injury, and dysfunction in respiratory and other systems (Chen et al., 2024; Manisalidis et al., 2020).
*   **Inflammation:** PM2.5 interaction with lung epithelial cells and macrophages triggers the release of pro-inflammatory mediators (cytokines like TNF-α, IL-1β, IL-6, IL-8, IL-17; chemokines) (Duan et al., 2024; Sangkham, 2024). This recruits inflammatory cells, causing local lung inflammation (contributing to asthma, COPD) (Xing et al., 2016; Sangkham, 2024) and potentially spilling over into systemic circulation (Duan et al., 2024). Chronic systemic inflammation, marked by elevated CRP and IL-6 (Sangkham, 2024; Wang & Liu, 2023), drives cardiovascular pathology (endothelial dysfunction, atherosclerosis) (Brook et al., 2010; Sangkham, 2024) and contributes to metabolic and neurological effects (Source N/A).
*   **Genotoxicity:** As detailed previously, PM2.5 directly damages DNA (strand breaks, adducts, oxidative lesions) and causes chromosomal aberrations (Valavanidis et al., 2020; Sangkham, 2024). Crucially, it may also impair DNA repair pathways, increasing the likelihood of mutations and genomic instability, contributing to cancer risk (Valavanidis et al., 2020).
*   **Systemic Translocation:** Fine and especially ultrafine particles can cross the alveolar-capillary barrier, entering the bloodstream (Duan et al., 2024; Garcia et al., 2023). These translocated particles can directly interact with cardiovascular tissues (Brook et al., 2010), cross the blood-brain barrier (potentially via circulation or the olfactory nerve) (Lucchini et al., 2012; Block & Calderón-Garcidueñas, 2009), and reach other organs, causing local inflammation and oxidative stress (Source N/A). This provides a direct pathway for systemic effects beyond indirect inflammatory signaling (Duan et al., 2024).
*   **Autonomic Nervous System (ANS) Imbalance:** Exposure can perturb ANS control, often leading to reduced heart rate variability, indicating increased sympathetic or decreased parasympathetic tone (Brook et al., 2010; Rajagopalan et al., 2020). This contributes to increased heart rate, blood pressure, and arrhythmia risk (Rajagopalan et al., 2020).
*   **Other Mechanisms:** Additional pathways include impaired lung clearance mechanisms (Xing et al., 2016), direct epithelial injury (Xing et al., 2016), promotion of prothrombotic states (platelet activation, coagulation) (Brook et al., 2010; deSouza et al., 2021), immunotoxicity (disrupting immune responses like Th1/Th2 balance) (Sangkham, 2024), induction of apoptosis (programmed cell death) in lung and endothelial cells (Sangkham, 2024), and epigenetic modifications (changes in DNA methylation, noncoding RNA expression) that can alter gene regulation and contribute to disease (Duan et al., 2024; Sangkham, 2024; Wang & Liu, 2023).

## Global Burden and Conclusion

The collective evidence synthesized from recent research provides a clear and consistent picture: exposure to PM2.5 poses significant and diverse threats to human health (Garcia et al., 2023; Sangkham, 2024; WHO, 2021). Both short-term and long-term exposures are linked to increased mortality and morbidity, primarily affecting the cardiovascular and respiratory systems but also extending to metabolic, neurological, reproductive, and carcinogenic outcomes (Xing et al., 2016; Rajagopalan et al., 2020; Garcia et al., 2023; WHO, 2021). The classification of PM from outdoor air pollution as a Group 1 human carcinogen by IARC highlights the severity of this risk (IARC, 2016; Loomis et al., 2014).

The underlying pathophysiology involves a complex interplay of mechanisms initiated by particle deposition in the lungs, centrally featuring oxidative stress and inflammation (Chen et al., 2024; Valavanidis et al., 2020; Sangkham, 2024). These processes, along with genotoxicity, autonomic nervous system disruption, and the potential for direct particle translocation, drive systemic effects far beyond the respiratory tract (Duan et al., 2024; Brook et al., 2010; Rajagopalan et al., 2020). The ability of PM2.5 to induce DNA damage while potentially impairing repair mechanisms is particularly concerning for long-term disease risk, including cancer (Valavanidis et al., 2020).

Globally, PM2.5 is a leading environmental risk factor (State of Global Air, n.d.; IHME, n.d.-a), responsible for millions of premature deaths annually (e.g., 4.14 million in GBD 2019 [Li et al., 2022]; 4.72 million in GBD 2021 [IHME, n.d.-a]; 8.1 million total air pollution deaths in 2021 [HEI & IHME, 2024]) and a substantial burden of disease (e.g., 118.2 million DALYs from ambient PM2.5 in GBD 2019 [Li et al., 2022]; 120 million in GBD 2021 [IHME, n.d.-a]), disproportionately affecting vulnerable populations and low- and middle-income countries (State of Global Air, n.d.). Evidence suggests adverse effects occur even at levels below current regulatory standards (Liu et al., 2022; deSouza et al., 2021), indicating that further reductions in exposure, aiming towards WHO guidelines (WHO, 2021), are necessary to protect public health. Continued research, robust air quality management policies targeting sources and precursors, and public health interventions are essential to mitigate the profound health impacts of PM2.5 pollution worldwide (Rajagopalan et al., 2020; Sangkham, 2024; WHO, 2021).

### References

1.  AAQR. (n.d.-a). *Particle-bound PAHs and Chemical Composition, Sources and Health Risk of PM2.5 in a Highly Industrialized Area*. Aerosol and Air Quality Research. Retrieved April 16, 2025, from https://aaqr.org/articles/aaqr-21-03-oa-0047
2.  AAQR. (n.d.-b). *Potential Risks of PM2.5 in Urban and Suburban Environments: A Dual Perspective on Chemical Constituents and Pollution Sources*. Aerosol and Air Quality Research. Retrieved April 16, 2025, from https://aaqr.org/articles/aaqr-23-12-oa-0315
3.  AAQR. (n.d.-c). *Untitled*. Aerosol and Air Quality Research. Retrieved April 16, 2025, from https://aaqr.org/articles/aaqr-22-06-oa-0247
4.  Agency for Toxic Substances and Disease Registry (ATSDR). (n.d.). *Particulate Matter Guidance*. Retrieved April 16, 2025, from https://www.atsdr.cdc.gov/pha-guidance/resources/ATSDR-Particulate-Matter-Guidance-508.pdf
5.  Al-Kindi, S. G., Brook, R. D., Biswal, S., & Rajagopalan, S. (2020). Environmental determinants of cardiovascular disease: lessons learned from air pollution. *Nature Reviews Cardiology*, *17*(10), 656–672. https://doi.org/10.1038/s41569-020-0371-2
6.  Alter, N. C., Whitman, E. M., Bellinger, D. C., & Landrigan, P. J. (2024). Quantifying the association between PM2.5 air pollution and IQ loss in children: a systematic review and meta-analysis. *Environmental Health*, *23*(1), 101. https://doi.org/10.1186/s12940-024-01122-x
7.  American Lung Association. (n.d.-a). *Health Impact of Pollution*. State of the Air. Retrieved April 16, 2025, from https://www.lung.org/research/sota/health-risks
8.  American Lung Association. (n.d.-b). *Health Risks of Particle Pollution*. Retrieved April 16, 2025, from https://www.lung.org/getmedia/0f48236b-5d24-4a0a-bef8-a32d34a31856/2020-particle-pollution-factsheet-final.pdf
9.  Apte, J. S., Marshall, J. D., Cohen, A. J., & Brauer, M. (2015). Addressing Global Mortality from Ambient PM2.5. *Environmental Science & Technology*, *49*(13), 8057–8066. https://doi.org/10.1021/acs.est.5b01236
10. Apte, J. S., Brauer, M., Cohen, A. J., Ezzati, M., & Pope III, C. A. (2018). Ambient PM2.5 Reduces Global and Regional Life Expectancy. *Environmental Science & Technology Letters*, *5*(9), 546–551. https://doi.org/10.1021/acs.estlett.8b00360
11. BiomassMurder.org. (n.d.). *April 11, 2019 EPA-CASAC-19-002 The Honorable Andrew R. Wheeler Administrator U.S. Environmental Protection Agency 1200 Pennsylv*. Retrieved April 16, 2025, from https://biomassmurder.org/docs/2019-04-11-epa-gov-integrated-science-assessment-for-particulate-matter-english.pdf
12. Block, M. L., & Calderón-Garcidueñas, L. (2009). Air pollution: mechanisms of neuroinflammation and CNS disease. *Trends in Neurosciences*, *32*(9), 506–516. https://doi.org/10.1016/j.tins.2009.05.009
13. Bourdrel, T., Bind, M. A., Béjot, Y., Morel, O., & Argacha, J. F. (2017). Cardiovascular effects of air pollution. *Archives of Cardiovascular Diseases*, *110*(11), 634–642. https://doi.org/10.1016/j.acvd.2017.05.003 (Cited in EEA, 2023)
14. Brook, R. D., Rajagopalan, S., Pope, C. A., III, Brook, J. R., Bhatnagar, A., Diez-Roux, A. V., Holguin, F., Hong, Y., Luepker, R. V., Mittleman, M. A., Peters, A., Siscovick, D., Smith, S. C., Jr., Whitsel, L., & Kaufman, J. D. (2010). Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association. *Circulation*, *121*(21), 2331–2378. https://doi.org/10.1161/CIR.0b013e3181dbece1
15. Bumrungrad International Hospital. (n.d.). *The Health Risks of PM 2.5*. Retrieved April 16, 2025, from https://www.bumrungrad.com/en/health-blog/january-2024/the-health-risks-of-pm-2-5
16. Burnett, R., Chen, H., Szyszkowicz, M., Fann, N., Hubbell, B., Pope III, C. A., Apte, J. S., Brauer, M., Cohen, A., Weichenthal, S., Coggins, J., Di, Q., Brunekreef, B., Frostad, J., Lim, S. S., Kan, H., Walker, K. D., Thurston, G. D., Hayes, R. B., … Ezzati, M. (2018). Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. *Proceedings of the National Academy of Sciences*, *115*(38), 9592–9597. https://doi.org/10.1073/pnas.1803222115
17. California Air Resources Board (CARB). (n.d.-a). *Inhalable Particulate Matter and Health (PM2.5 and PM10 ...)*. Retrieved April 16, 2025, from https://ww2.arb.ca.gov/resources/inhalable-particulate-matter-and-health
18. California Air Resources Board (CARB). (n.d.-b). *Summary: Diesel Particulate Matter Health Impacts*. Retrieved April 16, 2025, from https://ww2.arb.ca.gov/resources/summary-diesel-particulate-matter-health-impacts
19. Cesaroni, G., Forastiere, F., Stafoggia, M., Andersen, Z. J., Badalone, C., Beelen, R., ... & Hoek, G. (2014). Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE project. *Environmental Health Perspectives*, *122*(3), 324–330. https://doi.org/10.1289/ehp.1307301 (Cited in EEA, 2023)
20. Chen, R., Yin, P., Meng, X., Liu, C., Wang, L., Xu, X., Rossnagel, K., Kan, H., & Zhou, M. (2017). Associations between coarse particulate matter air pollution and cause-specific mortality: A nationwide analysis in 272 Chinese cities. *Environmental Health Perspectives*, *125*(5), 057008. https://doi.org/10.1289/EHP595
21. Chen, Z., Jaligama, S., & Wang, L. (2024). Oxidative stress is the pivot for PM2.5-induced lung injury. *Toxicology Research*, *13*(1), 1–13. https://doi.org/10.1093/toxres/tfad077
22. Clarity Movement. (n.d.). *Air Quality Measurements Series: Particulate Matter*. Retrieved April 16, 2025, from https://www.clarity.io/blog/air-quality-measurements-series-particulate-matter
23. Cohen, A. J., Brauer, M., Burnett, R., Anderson, H. R., Frostad, J., Estep, K., ... & Forouzanfar, M. H. (2017). Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. *The Lancet*, *389*(10082), 1907–1918. https://doi.org/10.1016/S0140-6736(17)30505-6 (Cited in EEA, 2023)
24. Colín-Val, Z., Ortega-Gómez, A., Cervantes-García, D., Bazán-Méndez, C. I., Alarcón-Romero, L. D. C., & López-Camarillo, C. (2024). The role of PM2.5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications. *Molecular Oncology*, *18*(11), 2844–2865. https://doi.org/10.1002/1878-0261.13681
25. Croft, D. P., Zhang, W., Lin, S., Thurston, S. W., Hopke, P. K., Masiol, M., & Rich, D. Q. (2019). Associations between sources of fine particulate matter and risk of asthma exacerbations. *Journal of Exposure Science & Environmental Epidemiology*, *29*(6), 800–811. https://doi.org/10.1038/s41370-019-0141-6
26. Dai, H., Zhang, Y., Huang, Z., Zhang, T., Wang, W., & Qian, Z. M. (2022). Cardiovascular mortality risk associated with ambient black carbon: A systematic review and meta-analysis. *Science of the Total Environment*, *806*(Pt 1), 150366. https://doi.org/10.1016/j.scitotenv.2021.150366 (Cited in EEA, 2023)
27. deSouza, P., Braun, D., Parks, R. M., Schwartz, J., Dominici, F., & Kioumourtzoglou, M.-A. (2021). Nationwide Study of Short-Term Exposure to Fine Particulate Matter and Cardiovascular Hospitalizations Among Medicaid Enrollees. *Epidemiology*, *32*(1), 6–13. https://doi.org/10.1097/EDE.0000000000001265
28. Di, Q., Wang, Y., Zanobetti, A., Wang, Y., Koutrakis, P., Choirat, C., Dominici, F., & Schwartz, J. D. (2017). Air Pollution and Mortality in the Medicare Population. *New England Journal of Medicine*, *376*(26), 2513–2522. https://doi.org/10.1056/NEJMoa1702747 (Provides HRs consistent with text, e.g., IHD HR 1.10 per 10ug/m3)
29. Duan, C., Jia, L., Chen, H., & Zhang, L. (2024). Particulate matter-induced epigenetic modifications and lung complications. *European Respiratory Review*, *33*(174), 240129. https://doi.org/10.1183/16000617.0129-2024
30. Edgerton, E. S., Hartsell, B. E., Saylor, R. D., Jansen, J. J., Hansen, D. A., & Hidy, G. M. (2014). Composition and sources of fine particulate matter across urban and rural sites in the Midwestern United States. *Atmospheric Environment*, *96*, 194–205. https://doi.org/10.1016/j.atmosenv.2014.07.033
31. Environmental Protection Authority Victoria. (n.d.). *PM2.5 particles in the air*. Retrieved April 16, 2025, from https://www.epa.vic.gov.au/for-community/environmental-information/air-quality/pm25-particles-in-the-air
32. European Environment Agency (EEA). (2021). *Air quality in Europe 2021*. EEA Report No 15/2021. https://www.eea.europa.eu/publications/air-quality-in-europe-2021 (Cited in EEA, 2023)
33. European Environment Agency (EEA). (2022). *Air quality in Europe 2022*. EEA Report No 05/2022. https://www.eea.europa.eu/publications/air-quality-in-europe-2022 (Cited in EEA, 2023)
34. European Environment Agency (EEA). (2023). *Beating cardiovascular disease — the role of Europe's environment*. EEA Report No 09/2023. https://www.eea.europa.eu/publications/beating-cardiovascular-disease
35. Fairbanks North Star Borough. (n.d.). *What is PM2.5?*. Retrieved April 16, 2025, from https://www.fnsb.gov/387/What-is-PM25
36. Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., ... & Murray, C. J. L. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. *The Lancet Neurology*, *20*(10), 795–820. https://doi.org/10.1016/S1474-4422(21)00252-0 (Cited in EEA, 2023)
37. Folino, A. F., Zangirolami-Raimundo, J., Raimundo, R. D., Ferraz, J. G. P., Gongora, D. V., Constantin, A. M., Menti, E., Oliveira, C. R., Gongora, H., & Godoy, M. F. (2017). Heart rate variability and environmental condition: analysis of particulate matter effects on autonomic modulation in healthy subjects. *Revista Portuguesa de Cardiologia (English Edition)*, *36*(10), 711–719. https://doi.org/10.1016/j.repc.2017.01.013
38. Fuks, K. B., Weinmayr, G., Foraster, M., Dratva, J., Hampel, R., Houthuijs, D., Oftedal, B., Oudin, A., Panasevich, S., Penell, J., Sommar, J. N., Sørensen, M., Stafoggia, M., Tittanen, P., Wolf, K., Xun, W. W., Aguilera, I., Basagaña, X., Beelen, R., … Hoffmann, B. (2016). Arterial blood pressure and long-term exposure to traffic-related air pollution: An analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE). *Environmental Health Perspectives*, *125*(1), 98–104. https://doi.org/10.1289/EHP34
39. Gallo, V., Vanacore, N., Schifano, P., Agabiti, N., Forastiere, F., Cascini, S., Mataloni, F., Cerza, F., Davoli, M., & Ancona, C. (2020). Effect of air pollution on hospital admissions for atrial fibrillation in Rome, Italy. *European Journal of Epidemiology*, *35*(1), 61–69. https://doi.org/10.1007/s10654-019-00590-x
40. Garcia, A., Santa-Helena, E., De Falco, A., de Paula Ribeiro, J., Gioda, A., & Gioda, C. R. (2023). Toxicological Effects of Fine Particulate Matter (PM2.5): Health Risks and Associated Systemic Injuries—Systematic Review. *Water, Air, & Soil Pollution*, *234*(6), 346. https://doi.org/10.1007/s11270-023-06278-9
41. GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. *The Lancet*, *396*(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9 (Cited in EEA, 2023)
42. Health Effects Institute (HEI) & Institute for Health Metrics and Evaluation (IHME). (2024). *State of Global Air 2024*. Retrieved from https://www.stateofglobalair.org/
43. Hehua, Z., Qing, Y., Jian, S., Juan, L., & Ying, Z. (2017). Ambient air pollution and hospital admission for pneumonia: a time-series analysis in Wuhan, China. *International Journal of Environmental Health Research*, *27*(4), 304–314. https://doi.org/10.1080/09603123.2017.1333012
44. Honda, T., Jorgensen, N. W., Chiu, Y.-H. M., Fitzgerald, G. L., Hauser, R., & Olsen, J. (2018). Long-term exposure to air pollution and blood pressure in a Danish cohort. *Journal of the American Heart Association*, *7*(24), e010633. https://doi.org/10.1161/JAHA.118.010633
45. Indoor Air Hygiene Institute. (n.d.). *PM2.5 Explained*. Retrieved April 16, 2025, from https://www.indoorairhygiene.org/pm2-5-explained/
46. Institute for Health Metrics and Evaluation (IHME). (n.d.-a). *Air pollution*. Retrieved April 16, 2025, from https://www.healthdata.org/research-analysis/health-risks-issues/air-pollution-research-library
47. Institute for Health Metrics and Evaluation (IHME). (n.d.-b). *Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East*. Retrieved April 16, 2025, from https://www.healthdata.org/research-analysis/library/effect-air-pollution-disease-burden-mortality-and-life-expectancy-north
48. International Agency for Research on Cancer (IARC). (2013, October 17). *IARC: Outdoor air pollution a leading environmental cause of cancer deaths* [Press Release No. 221]. https://www.iarc.who.int/wp-content/uploads/2018/07/pr221_E.pdf
49. International Agency for Research on Cancer (IARC). (2016). *Outdoor air pollution*. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 109. https://publications.iarc.fr/538
50. Jedrychowski, W. A., Perera, F. P., Spengler, J. D., Mroz, E., Stigter, L., Flak, E., Majewska, R., Klimaszewska-Rembiasz, M., & Jacek, R. (2013). Intrauterine exposure to fine particulate matter as a risk factor for increased susceptibility to acute broncho-pulmonary infections in early childhood. *International Journal of Hygiene and Environmental Health*, *216*(4), 395–401. https://doi.org/10.1016/j.ijheh.2012.09.004
51. Ji, X., Cohan, D. S., & Bell, M. L. (2022). Missing environmental justice: Lack of federal ambient air quality monitoring networks in historically redlined communities. *Energy Policy*, *167*, 113049. https://doi.org/10.1016/j.enpol.2022.113049 (Cited in EEA, 2023)
52. Jung, C.-R., Hwang, B.-F., & Chen, Y.-T. (2019). Air pollution and childhood asthma in Taichung, Taiwan. *Environmental Research*, *179*(Pt A), 108739. https://doi.org/10.1016/j.envres.2019.108739
53. Kaiterra. (n.d.). *The Three Types of Particulate Matter: All About PM10, PM2.5, and PM0.1*. Retrieved April 16, 2025, from https://learn.kaiterra.com/en/resources/three-types-of-particulate-matter
54. Kim, I.-S., Lee, J., Yang, H.-I., Lee, E., & Heo, J. (2019). Fine particulate matter and risk of incident atrial fibrillation. *European Heart Journal*, *40*(35), 2997–3005. https://doi.org/10.1093/eurheartj/ehz201
55. Li, X., Huang, S., Jiao, A., Yang, X., Yun, J., Wang, Y., & Xue, F. (2022). The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019. *Ecotoxicology and Environmental Safety*, *239*, 113588. https://doi.org/10.1016/j.ecoenv.2022.113588
56. Liu, R., Dominici, F., Wang, Y., Requia, W. J., Chen, K., & Schwartz, J. (2022). Short term exposure to air pollution and mortality in the US: a double negative control analysis. *Environmental Health*, *21*(1), 81. https://doi.org/10.1186/s12940-022-00886-4
57. Loomis, D., Huang, W., & Chen, G. (2014). The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China. *Chinese Journal of Cancer*, *33*(4), 189–196. https://doi.org/10.5732/cjc.014.10028
58. Lucchini, R. G., Kim, Y., & Landrigan, P. J. (2012). Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. *Environmental Health Perspectives*, *120*(8), 1089–1096. https://doi.org/10.1289/ehp.1104146
59. Manisalidis, I., Stavropoulou, E., Stavropoulos, A., & Bezirtzoglou, E. (2020). Environmental and Health Impacts of Air Pollution: A Review. *Frontiers in Public Health*, *8*, 14. https://doi.org/10.3389/fpubh.2020.00014
60. McDuffie, E. E., Martin, R. V., Spadaro, J. V., Burnett, R., Smith, S. J., O’Rourke, P., Hammer, M. S., van Donkelaar, A., Bindle, L., Shah, V., Jaeglé, L., Luo, G., Yu, F., Adeniran, J. A., Lin, J., & Brauer, M. (2021). Source sector and fuel contributions to ambient fine particulate matter and attributable mortality: estimates for 195 countries and territories. *Nature Communications*, *12*(1), 3594. https://doi.org/10.1038/s41467-021-23853-y
61. Mushtaq, N., Ezzati, M., Hall, L., Hogg, R., & Hirst, R. A. (2011). Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. *Respiratory Research*, *12*(1), 141. https://doi.org/10.1186/1465-9921-12-141
62. Nakić, S. N., Jakovljević, I., Šimić, I., Tkalec, M., Hršak, D., & Pehnec, G. (2021). Outdoor Air Pollution and Cancer: An Overview of the Current Evidence and Public Health Recommendations. *International Journal of Environmental Research and Public Health*, *18*(4), 1888. https://doi.org/10.3390/ijerph18041888
63. Newman, J. D., Bhatt, D. L., Rajagopalan, S., Balmes, J. R., Brauer, M., Breysse, P. N., Brown, A. G. M., Carnethon, M. R., Cascio, W. E., Collman, G. W., Fine, L. J., Hansel, N. N., Hernandez, A., Hochman, J. S., Jerrett, M., Joubert, B. R., Kaufman, J. D., Malik, A. O., Mensah, G. A., … Brook, R. D. (2020). Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review. *Journal of the American College of Cardiology*, *76*(24), 2878–2894. https://doi.org/10.1016/j.jacc.2020.10.020
64. Pinkerton, K. E., & Joad, J. P. (2006). Influence of air pollution on respiratory health during perinatal development. *Clinical and Experimental Pharmacology & Physiology*, *33*(3), 269–272. https://doi.org/10.1111/j.1440-1681.2006.04359.x
65. Pinkerton, K. E., Zhou, Y. M., Zhong, C., Smith, K. R., Teague, S. V., Kennedy, I. M., & Aust, A. E. (2000). Differential Deposition of Carbon Particulates in the Lungs of Neonatal Rats. *Environmental Health Perspectives*, *108*(11), 1061–1067. https://doi.org/10.1289/ehp.001081061
66. Rajagopalan, S., Al-Kindi, S. G., & Brook, R. D. (2018). Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review. *Journal of the American College of Cardiology*, *72*(17), 2054–2070. https://doi.org/10.1016/j.jacc.2018.07.099
67. Sang, S., Yang, J., Zhang, Y., Liu, M., & Zhao, C. (2022). Short-term effects of ambient carbon monoxide exposure on cardiovascular mortality: a systematic review and meta-analysis. *Environmental Science and Pollution Research International*, *29*(12), 16819–16830. https://doi.org/10.1007/s11356-021-16864-x (Cited in EEA, 2023)
68. Sangkham, S. (2024). An update on adverse health effects from exposure to PM2.5. *Environmental Advances*, *18*, 100603. https://doi.org/10.1016/j.envadv.2024.100603
69. Schulze, F., Gao, X., Virzonis, D., Damiati, S., Schneider, M. R., & Flemig, S. (2017). Air pollution-on-a-chip: A new platform to study the cytotoxicity of airborne pollutants. *Scientific Reports*, *7*(1), 11341. https://doi.org/10.1038/s41598-017-11341-1
70. Schwartz, J., Laden, F., & Zanobetti, A. (2002). The concentration-response relation between PM(2.5) and daily deaths. *Environmental Health Perspectives*, *110*(10), 1025–1029. https://doi.org/10.1289/ehp.021101025
71. Seihei, K., Masayuki, S., & Shinji, O. (2024). Association Between Particulate Matter 2.5 and Exacerbations of Asthma in Japan: A Systematic Review and Meta-Analysis. *Cureus*, *16*(1), e51487. https://doi.org/10.7759/cureus.51487
72. Shi, L., Ma, Y., Dong, J., Van Donkelaar, A., Martin, R. V., Liu, Y., Sarnat, J. A., Sabath, M. B., & Chang, H. H. (2023). Associations of long-term exposure to ambient PM2.5 constituents with mortality: A systematic review and meta-analysis. *Environmental Pollution*, *325*, 121444. https://doi.org/10.1016/j.envpol.2023.121444
73. Song, Y., Zhang, Y., Xie, S., Zeng, L., Zheng, M., Salmon, L. G., Shao, M., & Slanina, S. (2010). Source apportionment of PM2.5 in Beijing by positive matrix factorization. *Atmospheric Environment*, *44*(1), 153–161. https://doi.org/10.1016/j.atmosenv.2009.10.039
74. State of Global Air. (n.d.). *Health Impacts of PM2.5*. Retrieved April 16, 2025, from https://www.stateofglobalair.org/health/pm
75. Strosnider, H. M., Chang, H. H., Darrow, L. A., Liu, Y., Vaidyanathan, A., & Strickland, M. J. (2019). Age-specific associations of ozone and PM2.5 with respiratory emergency department visits in the US. *American Journal of Respiratory and Critical Care Medicine*, *199*(7), 882–890. https://doi.org/10.1164/rccm.201806-1147OC
76. Sukuman, N., Ishak, A., & Yusop, Z. (2023). Health impacts from PM2.5 exposure using environmental epidemiology and health risk assessment: A review. *Sustainability*, *15*(15), 11918. https://doi.org/10.3390/su151511918
77. Tian, Y., Liu, H., Si, Y., Cao, Y., Xiang, X., Wu, Y., Wu, Y., Juan, J., Li, M., & Chen, W. (2017). Association between ambient fine particulate matter and hospital outpatient visits for asthma in Shanghai, China. *Science of The Total Environment*, *574*, 160–165. https://doi.org/10.1016/j.scitotenv.2016.09.034
78. U.S. Environmental Protection Agency (EPA). (n.d.-a). *EPA-CASAC-10-001 unsigned Report Integrated Science Assessment*. Retrieved April 16, 2025, from https://ordspub.epa.gov/ords/eims/eimscomm.getfile?p_download_id=508496
79. U.S. Environmental Protection Agency (EPA). (n.d.-b). *Guidelines for Carcinogen Risk Assessment*. Retrieved April 16, 2025, from https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf
80. U.S. Environmental Protection Agency (EPA). (n.d.-c). *Health and Environmental Effects of Particulate Matter (PM)*. Retrieved April 16, 2025, from https://www.epa.gov/pm-pollution/health-and-environmental-effects-particulate-matter-pm
81. U.S. Environmental Protection Agency (EPA). (n.d.-d). *Particulate Matter (PM) Basics*. Retrieved April 16, 2025, from https://www.epa.gov/pm-pollution/particulate-matter-pm-basics
82. U.S. Environmental Protection Agency (EPA). (n.d.-e). *Particulate Matter (PM2.5) Trends*. Retrieved April 16, 2025, from https://www.epa.gov/air-trends/particulate-matter-pm25-trends
83. U.S. Environmental Protection Agency (EPA). (n.d.-f). *Provisional Assessment of Recent Studies on Health Effects of Particulate Matter Exposure*. Retrieved April 16, 2025, from https://ordspub.epa.gov/ords/eims/eimscomm.getfile?p_download_id=508978
84. U.S. Environmental Protection Agency (EPA). (n.d.-g). *Risk Assessment for Carcinogenic Effects*. Retrieved April 16, 2025, from https://www.epa.gov/fera/risk-assessment-carcinogenic-effects
85. U.S. Environmental Protection Agency (EPA). (n.d.-h). *PM2.5 Chemical Composition Overview*. Retrieved April 16, 2025, from https://www3.epa.gov/pmdesignations/2012standards/docs/pm2.5_chemical_composition.pdf
86. Valavanidis, A., Fiotakis, K., Vlachogianni, T., & Papaioannou, A. (2020). DNA damage by fine particulate matter (PM2.5): Genotoxicity evaluation of airborne PM2.5 levels in the city of Athens, Greece. *International Journal of Environmental Research and Public Health*, *17*(13), 4874. https://doi.org/10.3390/ijerph17134874
87. Vicedo-Cabrera, A. M., Sera, F., Liu, C., Armstrong, B., Milojevic, A., Guo, Y., Tong, S., Lavigne, E., Kyselý, J., Urban, A., Schneider, A., Kan, H., Cruz, J. C., Íñiguez, C., Tobias, A., Zeka, A., Hashizume, M., Honda, Y., Kim, H., … Gasparrini, A. (2020). Short term association between ozone and mortality: global meta analysis and huge data study. *BMJ*, *368*, m108. https://doi.org/10.1136/bmj.m108
88. Vibhavadi Hospital. (n.d.). *The Dangers of PM2.5*. Retrieved April 16, 2025, from https://www.vibhavadi.com/en/blogs/the-dangers-of-pm2-5
89. Wang, Q., & Liu, S. (2023). The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease. *International Journal of Chronic Obstructive Pulmonary Disease*, *18*, 493–506. https://doi.org/10.2147/COPD.S402122
90. Wang, S., Zhang, J., Zeng, X., Sun, B., Wang, L., & Van Den Eeden, S. K. (2017). Association of traffic-related air pollution with children's neurobehavioral functions in Quanzhou, China. *Environmental Health*, *16*(1), 1. https://doi.org/10.1186/s12940-016-0208-1
91. Wang, H., Saiz-Lopez, A., Cuevas, C. A., Li, S., Lu, X., Denjean, C., Wang, S., Liu, Y., Dada, L., Schervish, M., Yan, C., Chen, Y., Kuang, Y., Wang, M., Yao, L., Yin, R., Bianchi, F., Petäjä, T., Kerminen, V.-M., … Wang, L. (2023). Rapid night-time oxidation of anthropogenic sulfur dioxide enhances haze formation. *Science*, *382*(6677), 1415–1420. https://doi.org/10.1126/science.adg0748
92. Whaley, P., Halsall, C., Ågerstrand, M., Aiassa, E., Bilotta, G., Bouwmeester, H., ... & Hoffmann, S. (2021). Implementing systematic review methods in chemical risk assessment: challenges, opportunities and recommendations. *Environment International*, *156*, 106652. https://doi.org/10.1016/j.envint.2021.106652 (Cited in WHO, 2021 Annex)
93. Wolf, K., Hoffmann, B., Andersen, Z. J., Atkinson, R. W., Bauwelinck, M., Bellander, T., ... & Samoli, E. (2021). Long-term exposure to low-level ambient air pollution and incidence of stroke and coronary heart disease: a pooled analysis of six European cohorts within the ELAPSE project. *The Lancet Planetary Health*, *5*(9), e620–e632. https://doi.org/10.1016/S2542-5196(21)00195-9 (Cited in EEA, 2023)
94. World Health Organization (WHO). (2013). *Review of evidence on health aspects of air pollution – REVIHAAP Project Technical Report*. WHO Regional Office for Europe.
95. World Health Organization (WHO). (2021). *WHO global air quality guidelines: particulate matter (‎PM2.5 and PM10)‎, ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide*. World Health Organization. https://iris.who.int/handle/10665/345329
96. Wu, X., Nethery, R. C., Sabath, B. M., Braun, D., & Dominici, F. (2020). Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study. *medRxiv*. https://doi.org/10.1101/2020.04.05.20054502
97. Xia, X., Zhang, A., Liang, S., Liu, S., & Zhang, L. (2017). Acute effects of ambient air pollution on hospital admissions for respiratory diseases in Lanzhou, China. *Environmental Pollution*, *227*, 563–570. https://doi.org/10.1016/j.envpol.2017.04.096
98. Xie, W., Li, G., Zhao, D., Xie, X., Wei, Z., Wang, W., Wang, M., Sun, J., Sun, Y., Li, T., & Yang, H. (2018). Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. *Heart*, *104*(12), 1004–1010. https://doi.org/10.1136/heartjnl-2017-312758
99. Xing, Y.-F., Xu, Y.-H., Shi, M.-H., & Lian, Y.-X. (2016). The impact of PM2.5 on the human respiratory system. *Journal of Thoracic Disease*, *8*(1), E69–E74. https://doi.org/10.3978/j.issn.2072-1439.2016.01.19
100. Xu, M., Lin, Z., Li, Y., Liu, J., Guo, L., Zhang, R., Meng, F., & Li, X. (2016). Short-term effects of ambient fine particulate matter on daily emergency room visits for respiratory disease in Beijing, China. *Atmospheric Environment*, *143*, 126–134. https://doi.org/10.1016/j.atmosenv.2016.08.044
101. Xu, P., Chen, F., Zhao, Q., Su, J., Wang, Y., Yao, Y., Jiang, Z., & Lu, W. (2019). Protective effects of epigallocatechin-3-gallate against PM2.5-induced lung injury through the Nrf2 pathway. *Chemico-Biological Interactions*, *309*, 108716. https://doi.org/10.1016/j.cbi.2019.108716
102. Yang, C., Chen, R., Cui, P., Ma, J., & Liu, Y. (2020). Short-term effects of ambient fine particulate matter pollution on outpatient visits for cardiovascular diseases in China. *Environmental Science and Pollution Research International*, *27*(3), 3503–3512. https://doi.org/10.1007/s11356-019-07103-4
103. Zhang, Y., Duan, F., Mi, K., Zhu, L., He, K., Lu, Z., & Chang, S. (2015). Characteristics of atmospheric organic and elemental carbon in PM2.5 from Beijing, China. *Atmospheric Research*, *153*, 126–135. https://doi.org/10.1016/j.atmosres.2014.07.025
104. Zhang, J., Wang, H., Wang, P., Yang, Y., & Wang, Y. (2017). Association between PM2.5 concentration and hospital emergency room visits for respiratory disease in urban areas of Beijing, China. *Atmospheric Environment*, *150*, 81–88. https://doi.org/10.1016/j.atmosenv.2016.11.048
105. Zhao, B., Johnston, A. S., & Wang, Y. (2018). PM2.5-related health impacts of using cleaner household stoves in China. *Environmental Research Letters*, *13*(9), 094008. https://doi.org/10.1088/1748-9326/aad942
